The German agro-chemical group Bayer announced Wednesday the withdrawal in the United States of its offer of $ 1.25 billion to deal with future litigation on glyphosate, after reservations expressed by a judge.
Bayer has agreed to "withdraw the request for prior consent" to allow him to escape "possible future prosecution" on cases of cancer allegedly linked to the use of glyphosate, the group said in a statement.
The deal was to cost him between ten and eleven billion dollars
The company had announced at the end of June an agreement which would cost it between ten and eleven billion dollars to settle more than one hundred thousand disputes in the United States alone and especially concerning Round'Up, a glyphosate-based pesticide marketed by its subsidiary. Monsanto.
Problem: a Californian magistrate on Tuesday expressed reservations about the validity of the latter. The group's proposal to set up an independent scientific committee, which would decide judges and jurors for future prosecutions, is clearly going badly.
By its decision, Bayer now wants to allow the parties concerned "to resolve the recent problems raised by the judge," said his press release. The group "remains firmly committed to a solution that both resolves current legal disputes and contains a viable solution to deal with and settle possible future proceedings," he adds.
Thousands of complaints worldwide
Having bought its rival Monsanto in 2018 for $ 63 billion, the German group has since faced thousands of complaints around the world about the alleged cancer risks linked to the use of Monsanto weed killers such as Roundup. On the stock market, the Bayer share fell on Wednesday by 0.63% to 63.35 euros, after a plunge of more than 5% the day before.
World
Roundup: Bayer to compensate US plaintiffs up to $ 10 billion
Planet
"I only aspire to return to a normal life," says Paul François, the farmer at war with Monsanto
- Justice
- Video
- Pesticides
- Planet
- Glyphosate
- Monsanto
- Economy
- World